Clinical Trials
6 trialsNCT00036920 2013-06-26
TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00088556 2012-05-31
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Telik
Phase 1/2 Completed
NCT00040638 2011-07-25
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
Telik
Phase 2 Completed
NCT00047801 2011-07-25
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
Telik
Phase 1/2 Completed
NCT00077883 2011-07-25
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Telik
Phase 1/2 Completed
NCT00080340 2008-01-15
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Telik
Phase 3 Completed